ETC
DXCM icon

Exchange Traded Concepts’s DexCom DXCM Stock Holding History

Exchange Traded Concepts’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.1M Buy
304,284
+302,284
+15,114% +$21.1M 0.14% 169
2025
Q4 		$133K Sell
2,000
-8,031
-80% -$519K ﹤0.01% 1313
2025
Q3 		$675K Buy
10,031
+1,271
+15% +$101K 0.01% 952
2025
Q2 		$765K Sell
8,760
-1,552
-15% -$122K 0.01% 795
2025
Q1 		$704K Sell
10,312
-438
-4% -$35.7K 0.01% 718
2024
Q4 		$836K Sell
10,750
-1,526
-12% -$113K 0.02% 635
2024
Q3 		$823K Buy
12,276
+3,474
+39% +$285K 0.02% 594
2024
Q2 		$998K Buy
8,802
+1,047
+14% +$132K 0.03% 438
2024
Q1 		$1.08M Sell
7,755
-1,775
-19% -$223K 0.03% 420
2023
Q4 		$1.18M Sell
9,530
-3,808
-29% -$389K 0.03% 368
2023
Q3 		$1.24M Buy
13,338
+306
+2% +$34.5K 0.04% 332
2023
Q2 		$1.67M Sell
13,032
-619
-5% -$74.9K 0.04% 294
2023
Q1 		$1.59M Sell
13,651
-1,669
-11% -$187K 0.04% 244
2022
Q4 		$1.73M Sell
15,320
-5,000
-25% -$549K 0.05% 204
2022
Q3 		$1.64M Sell
20,320
-3,545
-15% -$300K 0.05% 172
2022
Q2 		$1.78M Buy
23,865
+3,181
+15% +$290K 0.05% 179
2022
Q1 		$2.65M Sell
20,684
-7,500
-27% -$820K 0.05% 184
2021
Q4 		$3.78M Sell
28,184
-372
-1% -$53.5K 0.07% 159
2021
Q3 		$3.9M Sell
28,556
-7,452
-21% -$940K 0.1% 131
2021
Q2 		$3.84M Buy
36,008
+1,764
+5% +$169K 0.12% 121
2021
Q1 		$3.08M Buy
34,244
+8,712
+34% +$818K 0.12% 126
2020
Q4 		$2.36M Buy
25,532
+17,876
+233% +$1.6M 0.11% 115
2020
Q3 		$789K Buy
7,656
+4,928
+181% +$515K 0.04% 189
2020
Q2 		$276K Sell
2,728
-248
-8% -$22.2K 0.05% 408
2020
Q1 		$200K Buy
2,976
+1,204
+68% +$74.9K 0.11% 203
2019
Q4 		$97K Buy
+1,772
New +$84K 0.02% 199

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Exchange Traded Concepts's DXCM Position: Q1 2026 in Review

Exchange Traded Concepts increased its DexCom (DXCM) stake by 15,114% in Q1 2026, buying an estimated $21.1M and bringing the position to 304,284 shares worth $19.1M. The position accounts for 0.14% of the portfolio, ranked #169.

Exchange Traded Concepts first reported a position in DXCM in Q4 2019 and has held it in 26 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Exchange Traded Concepts held 304,284 shares of DexCom worth $19.1M as of Q1 2026.
  • Exchange Traded Concepts bought 302,284 DexCom shares in Q1 2026, an estimated $21.1M.
  • DexCom made up 0.14% of Exchange Traded Concepts's portfolio in Q1 2026, its #169 holding.
  • Exchange Traded Concepts first reported a position in DexCom in Q4 2019 and has held it in 26 quarters since.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.